Jain, P., Verstovsek, S., Loghavi, S., Jorgensen, J. L., Patel, K. P., Estrov, Z., . . . Pemmaraju, N. (2015). Durable remission with rituximab in a patient with an unusual variant of Castleman's disease with myelofibrosis—TAFRO syndrome. Am J Hematol.
Chicago-stil citatJain, Preetesh, Srdan Verstovsek, Sanam Loghavi, Jeffrey L. Jorgensen, Keyur P. Patel, Zeev Estrov, Luis Fayad, och Naveen Pemmaraju. "Durable Remission With Rituximab in a Patient With an Unusual Variant of Castleman's Disease With Myelofibrosis—TAFRO Syndrome." Am J Hematol 2015.
MLA-referensJain, Preetesh, et al. "Durable Remission With Rituximab in a Patient With an Unusual Variant of Castleman's Disease With Myelofibrosis—TAFRO Syndrome." Am J Hematol 2015.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.